The Human Frontier Science Program Organization has awarded Stephen Quake the 2013 Nakasone Award for his work developing technologies in biophysics, biological automation, genome analysis, and personalized medicine. Quake is a professor of bioengineering and a Howard Hughes Medical Institute investigator at Stanford University. He is also a co-founder of Helicos Biosciences and Fluidigm.

Personalized medicine and molecular diagnostics firm Nodality has appointed pharmaceutical, biotech, and venture capital executive Laura Brege to serve as company president and CEO. Brege formerly was executive VP and COO at Onyx Pharmaceuticals, and she was a general partner at Red Rock Capital Management. She also was senior VP and CFO at COR Therapeutics, CFO at Flextronics, and treasurer of The Cooper Companies.

The National Center for Advancing Translational Sciences has named Chris Austin to be the first director of the new center, which launched at the beginning of the year and has so far been run by Acting Director Thomas Insel. Austin began his National Institutes of Health career in 2002, after working as a genomics researcher at Merck, as a senior advisor to the director for translational research at the National Human Genome Research Institute.

See more here:
NantHealth, Blue Shield Partner on Personalized Medicine Venture

Comments are closed.